Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic M Walsh

Showing results (51-60 of 127) with videos related to

Pageof 13
Sort By:
Acta Neuropathologica|April 25, 2018
Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer's disease brainWei Hong, Zemin Wang, Wen Liu, et al.
Neuron|December 23, 2003
Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature deathMalcolm A Leissring, Wesley Farris, Alice Y Chang, et al.
Human Molecular Genetics|April 16, 2013
De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's diseaseHon-Kit Andus Wong, Tatiana Veremeyko, Nehal Patel, et al.
Biochemistry|June 5, 2003
gamma-Secretase cleavage and binding to FE65 regulate the nuclear translocation of the intracellular C-terminal domain (ICD) of the APP family of proteinsDominic M Walsh, Julia V Fadeeva, Matthew J LaVoie, et al.
Neurobiology of Disease|July 29, 2015
Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 miceAlexandra J Mably, Wen Liu, Jessica M Mc Donald, et al.
Nature|April 5, 2002
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivoDominic M Walsh, Igor Klyubin, Julia V Fadeeva, et al.
Cell Reports|May 17, 2018
Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer's Disease Disrupt Synaptic PlasticityNeng-Wei Hu, Grant T Corbett, Steven Moore, et al.
Brain Research|April 30, 2009
gamma-secretase processing of APLP1 leads to the production of a p3-like peptide that does not aggregate and is not toxic to neuronsAedín M Minogue, Adam K Stubbs, Carlo Sala Frigerio, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 20, 2011
Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion proteinAndrew E Barry, Igor Klyubin, Jessica M Mc Donald, et al.
Advanced Healthcare Materials|August 20, 2015
Targeted Magnetic Nanoparticles for Remote Magnetothermal Disruption of Amyloid-β AggregatesColleen N Loynachan, Gabriela Romero, Michael G Christiansen, et al.
Pageof 13

Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica|April 25, 2018
Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer's disease brainWei Hong, Zemin Wang, Wen Liu, et al.
Neuron|December 23, 2003
Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature deathMalcolm A Leissring, Wesley Farris, Alice Y Chang, et al.
Human Molecular Genetics|April 16, 2013
De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's diseaseHon-Kit Andus Wong, Tatiana Veremeyko, Nehal Patel, et al.
Biochemistry|June 5, 2003
gamma-Secretase cleavage and binding to FE65 regulate the nuclear translocation of the intracellular C-terminal domain (ICD) of the APP family of proteinsDominic M Walsh, Julia V Fadeeva, Matthew J LaVoie, et al.
Neurobiology of Disease|July 29, 2015
Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 miceAlexandra J Mably, Wen Liu, Jessica M Mc Donald, et al.
Nature|April 5, 2002
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivoDominic M Walsh, Igor Klyubin, Julia V Fadeeva, et al.
Cell Reports|May 17, 2018
Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer's Disease Disrupt Synaptic PlasticityNeng-Wei Hu, Grant T Corbett, Steven Moore, et al.
Brain Research|April 30, 2009
gamma-secretase processing of APLP1 leads to the production of a p3-like peptide that does not aggregate and is not toxic to neuronsAedín M Minogue, Adam K Stubbs, Carlo Sala Frigerio, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 20, 2011
Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion proteinAndrew E Barry, Igor Klyubin, Jessica M Mc Donald, et al.
Advanced Healthcare Materials|August 20, 2015
Targeted Magnetic Nanoparticles for Remote Magnetothermal Disruption of Amyloid-β AggregatesColleen N Loynachan, Gabriela Romero, Michael G Christiansen, et al.
Pageof 13